Home Newsfeeds Rosenblatt Maintains Neutral on Juniper Networks, Lowers Price Target to $32

Rosenblatt Maintains Neutral on Juniper Networks, Lowers Price Target to $32

Rosenblatt analyst Mike Genovese maintains Juniper Networks (NYSE:JNPR) with a Neutral and lowers the price target from $33 to $32.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Rosenblatt analyst Mike Genovese maintains Juniper Networks (NYSE:JNPR) with a Neutral and lowers the price target from $33 to $32.

Analyst Ratings

In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics

By Benzinga Insights

April 18, 8:00 AM

Sage Therapeutics (NASDAQ:SAGE) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from…

SAGE

Cathie Wood Continues To Bulk Up On This Crypto-Linked Stock – Here Are Ark’s Other Notable Trades On Friday

By Shanthi Rexaline

February 25, 4:09 PM

Cathie Wood’s Ark Invest has recently been increasing bets on its portfolio stocks when they sell off, with the "buying the dip" approach reflecting its confidence in these stocks.

ARKK

Analyst Ratings

What 21 Analyst Ratings Have To Say About Estee Lauder Cos

By Benzinga Insights

December 6, 8:01 AM

Within the last quarter, Estee Lauder Cos (NYSE:EL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

ENDRA Life Sciences Q3 EPS $(0.05), Inline

By Benzinga Newsdesk

November 14, 5:18 PM

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.

NDRA

Rosenblatt Maintains Neutral on Juniper Networks, Lowers Price Target to $32

Related Posts

In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics

Cathie Wood Continues To Bulk Up On This Crypto-Linked Stock – Here Are Ark’s Other Notable Trades On Friday

What 21 Analyst Ratings Have To Say About Estee Lauder Cos

ENDRA Life Sciences Q3 EPS $(0.05), Inline